Author:
Gupta Nikhil,Gupta Arun K.,Krishnegowda Umesh,Bhardwaj Meenakshi,Naskar Dipankar,Durga C.K.
Publisher
Springer Science and Business Media LLC
Subject
Industrial and Manufacturing Engineering,Materials Science (miscellaneous),Business and International Management
Reference19 articles.
1. Kransdorf MJ. Malignant soft-tissue tumors in a large referral population: distribution of diagnoses by age, sex, and location. AJR Am J Roentgenol 1995;164:129–34.
2. Lemm D, Mugge LO, Mentzel T, et al. Current treatment options in dermatofibrosarcoma protuberans. J Cancer Res Clin Oncol 2009; 135:653–65.
3. Ammad Al-Tamimi, Sumbul Zaheer, Kesavan Sittampalam et al. Recurrent Dermatofibrosarcoma Protuberans of the Shoulder with Rare Distant Abdominal Metastasis detected by Fluorodeoxyglucose-Positron Emission Tomography/ Computed Tomography (FDG-PET/CT). Sultan Qaboos Univ Med J 2012; 12:371–4.
4. Kim GK. Status report on the management of dermatofibrosarcoma protuberans: is there a viable role for the use of imatinib mesylate? In which cases may it be therapeutically helpful and in which cases not? J Clin Aesthet Dermatol 2011;4:17–26.
5. Weiss SW and Nickoloff BJ. CD-34 is expressed by a distinctive cell population in peripheral nerve, nerve sheath tumors, and related lesions. Am J Surg Pathol 1993;17:1039–45.